Smithfield Bioscience, Inc.

Form 483 issued October 27, 2016 · Cincinnati, Ohio

Observations
4
Pages
3
FEI number
1527761

In short: On October 27, 2016, FDA issued a Form 483 with 4 observations to Smithfield Bioscience, Inc. in Cincinnati, Ohio (FEI 1527761). The investigator was Lindsey M. Schwierjohann. Most observations concern facilities & equipment and laboratory controls; the most-cited regulation is 21 CFR 211.68 (automatic, mechanical, and electronic equipment).

At a glance

Facilities & equipment and laboratory controls account for 3 of 4 observations.

Facilities & equipment2
Laboratory controls1
Production1

Most cited: 21 CFR 211.68 (2×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to validate laboratory…

  2. 02

    Oversight over the electronic systems and data in…

  3. 03

    The testing procedure for…

  4. 04

    Document control of production batch records by the…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Smithfield Bioscience, Inc.?

FDA listed 4 observations on this Form 483, mostly about facilities & equipment, laboratory controls and production. The most-cited regulation is 21 CFR 211.68 (automatic, mechanical, and electronic equipment). The opening words of each observation are shown on this page.

Who inspected Smithfield Bioscience, Inc.?

Lindsey M. Schwierjohann is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Smithfield Bioscience, Inc. inspected by FDA?

This Form 483 is dated October 27, 2016.

How do I get the full Form 483 for Smithfield Bioscience, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free